Durabilité à 4-5 ans – études Partner 3 & Evolut Low Risk
Structurel
You may also like this
Le TMVI en pratique – Nicolas Dumonteil
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] Le TMVI...
Activité structurel – Hakim Benamer
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] Activité structurel...
L’activité structurelle en 2023 – Hakim Benamer
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] L’activité structurelle...
FOP sans ETO – Philippe Aldebert
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] FOP sans...
Le traitement des bifurcations : nouvelles données – Hakim Benamer
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] Le traitement...
TAVI chez le patient asymptomatique – EARLY TAVR – Christophe Saint-Etienne
[vc_row bg_type="color" bg_color="#ffffff"][vc_column heading_color="primary-1" clipping_animation="clipping-down" animation_delay="400" css=".vc_custom_1656322571810{background-color: #ffffff !important;}"][vc_row_inner css=".vc_custom_1656320590127{padding-right: 2% !important;padding-left: 2% !important;}"][vc_column_inner width="3/4"][movedo_title heading_tag="h1" heading="h1" line_type="line"] TAVI chez...